Your search returned 4760 results.

Results
	2881.	Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide. [electronic resource] by Hingtgen, Shawn Ren, Xianghui Terwilliger, Ernie Classon, Marie Weissleder, Ralph Shah, Khalid Producer: 20081222 In: Molecular cancer therapeutics vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2882.	Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model. [electronic resource] by Mathieu, Véronique De Nève, Nancy Le Mercier, Marie Dewelle, Janique Gaussin, Jean-François Dehoux, Mischael Kiss, Robert Lefranc, Florence Producer: 20090424 In: Neoplasia (New York, N.Y.) vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2883.	Anti-proliferative effect of the gastrin-release peptide receptor antagonist RC-3095 plus temozolomide in experimental glioblastoma models. [electronic resource] by de Oliveira, Marianne Schrader Cechim, Giovana Braganhol, Elisandra Santos, Daniel Garcia Meurer, Luise de Castro, Cláudio Galvão Brunetto, Algemir Lunardi Schwartsmann, Gilberto Schwarstmann, Gilberto Battastini, Ana Maria Oliveira Lenz, Guido Roesler, Rafael Producer: 20090916 In: Journal of neuro-oncology vol. 93 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2884.	Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy. [electronic resource] by Jordan, Justin T Sun, Wei Hussain, S Farzana DeAngulo, Guillermo Prabhu, Sujit S Heimberger, Amy B Producer: 20080304 In: Cancer immunology, immunotherapy : CII vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2885.	Inhibition of coding region determinant binding protein sensitizes melanoma cells to chemotherapeutic agents. [electronic resource] by Craig, Evisabel A Spiegelman, Vladimir S Producer: 20120306 In: Pigment cell & melanoma research vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2886.	Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in mice. [electronic resource] by Sanchez-Perez, Luis A Choi, Bryan D Archer, Gary E Cui, Xiuyu Flores, Catherine Johnson, Laura A Schmittling, Robert J Snyder, David Herndon, James E Bigner, Darell D Mitchell, Duane A Sampson, John H Producer: 20130927 In: PloS one vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2887.	CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy. [electronic resource] by Waters, J Dawn Sanchez, Carlos Sahin, Ayguen Futalan, Diahnn Gonda, David D Scheer, Justin K Akers, Johnny Palanichamy, Kamalakannan Waterman, Peter Chakravarti, Arnab Weissleder, Ralph Morse, Brent Marsh, Nick Furfine, Eric Chen, Clark C Carvajal, Irvith Carter, Bob S Producer: 20130423 In: Journal of neuro-oncology vol. 110 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2888.	New treatment options with cytotoxic agents in neuroendocrine tumours. [electronic resource] by Hammel, Pascal Hentic, Olivia Neuzillet, Cindy Faivre, Sandrine Raymond, Eric Ruszniewski, Philippe Producer: 20130307 In: Targeted oncology vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2889.	MGMT is a molecular determinant for potency of the DNA-EGFR-combi-molecule ZRS1. [electronic resource] by Huang, Ying Rachid, Zakaria Jean-Claude, Bertrand J Producer: 20110711 In: Molecular cancer research : MCR vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2890.	Bevacizumab and irinotecan in the treatment of children with recurrent/refractory medulloblastoma. [electronic resource] by Aguilera, Dolly G Goldman, Steward Fangusaro, Jason Producer: 20110301 In: Pediatric blood & cancer vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2891.	A sphingosine kinase inhibitor combined with temozolomide induces glioblastoma cell death through accumulation of dihydrosphingosine and dihydroceramide, endoplasmic reticulum stress and autophagy. [electronic resource] by Noack, J Choi, J Richter, K Kopp-Schneider, A Régnier-Vigouroux, A Producer: 20150707 In: Cell death & disease vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2892.	Inhibition of Na+/K+-ATPase induces hybrid cell death and enhanced sensitivity to chemotherapy in human glioblastoma cells. [electronic resource] by Chen, Dongdong Song, Mingke Mohamad, Osama Yu, Shan Ping Producer: 20150706 In: BMC cancer vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2893.	Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials. [electronic resource] by Carlson, Julie A Reddy, Krishna Gaspar, Laurie E Ney, Douglas Kavanagh, Brian D Damek, Denise Lillehei, Kevin Chen, Changhu Producer: 20160225 In: Journal of neuro-oncology vol. 123 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2894.	Pancreatic Neuroendocrine Tumor Control: Durable Objective Response to Combination 177Lu-Octreotate-Capecitabine-Temozolomide Radiopeptide Chemotherapy. [electronic resource] by Claringbold, Phillip G Turner, J Harvey Producer: 20170516 In: Neuroendocrinology vol. 103 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2895.	Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for temozolomide. [electronic resource] by Rinne, Mikael L Wen, Patrick Y Producer: 20150527 In: Oncology (Williston Park, N.Y.) vol. 29 Availability: No items available. Save to lists Add to cart (remove)
	2896.	Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme. [electronic resource] by Kim, Young-Hoon Kim, Tackeun Joo, Jin-Deok Han, Jung Ho Kim, Yu Jung Kim, In Ah Yun, Chang-Ho Kim, Chae-Yong Producer: 20151104 In: Cancer vol. 121 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2897.	Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma. [electronic resource] by Lou, Emil Peters, Katherine B Sumrall, Ashley L Desjardins, Annick Reardon, David A Lipp, Eric S Herndon, James E Coan, April Bailey, Leighann Turner, Scott Friedman, Henry S Vredenburgh, James J Producer: 20140207 In: Cancer medicine vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2898.	Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution. [electronic resource] by Michaelsen, Signe Regner Christensen, Ib Jarle Grunnet, Kirsten Stockhausen, Marie-Thérése Broholm, Helle Kosteljanetz, Michael Poulsen, Hans Skovgaard Producer: 20140623 In: BMC cancer vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2899.	The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastoma. [electronic resource] by Tobias, Alex L Thaci, Bart Auffinger, Brenda Rincón, Esther Balyasnikova, Irina V Kim, Chung Kwon Han, Yu Zhang, Lingjiao Aboody, Karen S Ahmed, Atique U Lesniak, Maciej S Producer: 20130917 In: Stem cells translational medicine vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2900.	miR-181 subunits enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeleton remodeling in glioblastoma cells. [electronic resource] by She, Xiaoling Yu, Zhibin Cui, Yulong Lei, Qianqian Wang, Zeyou Xu, Gang Luo, Zhaohui Li, Guiyuan Wu, Minghua Producer: 20141022 In: Medical oncology (Northwood, London, England) vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 4760 results.